Holli Landin, PA
Medical · Lewisville, TXNPI 1730728528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,233 and has fallen 89.5% since, to $129 in 2023.
Across 87 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Clarus Therapeutics Inc.$275
- AbbVie$269
- Lilly USA, LLC$183
- Pfizer$138
- Biohaven Pharmaceuticals, Inc.$93
- Upsher-smith Laboratories LLC$63
- plus $407 from 14 others
What the payments were for
- Food & beverage$1,428100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Clarus Therapeutics Inc. | 15 | $275 |
| AbbVie | 22 | $269 |
| Lilly USA, LLC | 13 | $183 |
| Pfizer | 2 | $138 |
| Biohaven Pharmaceuticals, Inc. | 4 | $93 |
| Upsher-smith Laboratories LLC | 4 | $63 |
| Currax Pharmaceuticals LLC | 4 | $49 |
| Novo Nordisk | 3 | $48 |
| Antares Pharma, Inc. | 3 | $46 |
| Eisai Inc. | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $32 |
| Genentech USA, Inc. | 2 | $32 |
| AstraZeneca | 2 | $26 |
| Bayer | 1 | $20 |
| Neos Therapeutics, LP | 1 | $17 |
| Merck | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAXLOVID$114
How this compares
$1,428 in reported general payments places this provider in the 60th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Lewisville
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
- Janine ShinnDallas$84K
- Radha BernanderKaty$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.